Substance misuse in first-episode psychosis

The Recognition and Management of Early Psychosis: A Preventive Approach, Second Edition

Volumn , Issue , 2009, Pages 243-256

  Wade, Darryl ^a   Hides, Leanne ^a   Baker, Amanda ^b   Lubman, Dan ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77952820289     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511576287.015     Document Type: Chapter

References (88)

1. Addington, J. & Addington, D. (2001). Impact of an early psychosis programme on substance use. Psychiatric Rehabilitation Journal, 25, 60-7.
2. Andreasson, S., Allebeck, P., Engstrom, A. & Rydberg, U. (1987). Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet, u, 1483-6.
3. Arndt, S., Tyrrell, G., Flaum, M. & Andreasen, N. C. (1992). Comorbidity of substance abuse and schizophrenia: the role of premorbid adjustment. Psychological Medicine, 22, 379-88.
4. Arendt, M., Rosenberg, R., Foldager, L., Perto, G. & Munk- Jorgensen, P. (2005). Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases. British Journal of Psychiatry, 187, 510-15.
5. Arseneault, L., Cannon, M., Poulton, R. et al. (2002). Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. British Medical Journal, 325, 1212-13.
6. Arseneault, L., Cannon, M., Witton, J. & Murray, R. M. (2004). Causal association between cannabis and psychosis: examination of the evidence. British Journal of Psychiatry, 184, 110-17.
7. Baker, A., Lewin, T., Reichler, H. et al. (2002). Motivational interviewing among psychiatric in-patients with substance use disorders. Acta Psychiatrica Scandinavica, 106, 233-40.
8. Baker, A., Bucci, S. & Kay-Lambkin, F. (2004). Intervention for Alcohol, Cannabis and Amphetamine Use among People with a Psychotic Illness. [NDARC Technical Report No. 193.] Sydney: National Drug and Alcohol Research Centre.
9. Baker, A., Bucci, S., Lewin, T. J. et al. (2006a). Cognitive- behavioural therapy for substance use disorders in people with psychotic disorders: randomised controlled trial. British Journal of Psychiatry, 188, 439-48.
10. Baker, A., Richmond, R., Haile, M. et al. (2006b). Randomised controlled trial of a smoking cessation intervention among people with a psychotic disorder. American Journal of Psychiatry, 163, 1934-42.
11. Barrowclough, C., Haddock, G., Tarrier, N. et al. (2001) Randomized controlled trial of motivational interviewing, cognitive behaviour therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry, 158, 1706-13.
12. Blanchard, J.J., Squires, D., Henry, T. et al. (1999). Examining an affect regulation model of substance abuse in schizophrenia: the role of traits and coping. Journal of Nervous and Mental Disease, 187, 72-9.
13. Blanchard, J. J., Brown, S. A., Horan, W. P. & Sherwood, A. R. (2000). Substance use disorders in schizophrenia: review, integration, and a proposed model. Clinical Psychology Review, 20, 207-34.
14. Brown, S., Barraclough, B. & Inskip, H. (2000). Causes of the excess mortality of schizophrenia. British Journal of Psychiatry, 177, 212-17.
15. Cantwell, R., Brewin, J., Glazebrook, C. et al. (1999). Prevalence of substance misuse in first-episode psychosis. British Journal of Psychiatry, 174, 150-3.
16. Caspi, A., Moffitt, T.E., Cannon, M. et al. (2005). Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O- methyltransferase gene: longitudinal evidence of a gene x environment interaction. Biological Psychiatry, 57, 1117-27.
17. Chambers, R.A., Krystal, J.H. & Self, D.W. (2001). A neurobiological basis for substance abuse comorbidity in schizophrenia. Biological Psychiatry, 50, 71-83.
18. Coldham, E. L., Addington, J. & Addington, D. (2002). Medication adherence of individuals with a first episode of psychosis. Acta Psychiatrica Scandinavica, 106, 286-90.
19. Degenhardt, L. & Hall, W. (2001). The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-being. Psychological Medicine, 31, 659-68.
20. Degenhardt, L., Hall, W. & Lynskey, M. (2003). Testing hypotheses about the relationship between cannabis use and psychosis. Drug and Alcohol Dependence, 71, 37-48.
21. DeLisi, L. E., Boccio, A.M., Riordan, H. et al. (1991). Familial thyroid disease and delayed language development in first admission patients with schizophrenia. Psychiatry Research, 38, 39-50.
22. Dervaux, A., Bayle, F.J., Laqueille, X. et al. (2001). Is substance abuse in schizophrenia related to impulsivity, sensation seeking, or anhedonia? American Journal of Psychiatry, 158, 492-4.
23. Dixon, L., Haas, G., Weiden, P. J., Sweeney, J. & Frances, A. J. (1991). Drug abuse in schizophrenic patients: clinical correlates and reasons for use. American Journal of Psychiatry, 148, 224-30.
24. Drake, R. E., Mueser, K. T., Brunette, M. F. & McHugo, G. J. (2004). A review of treatments for people with severe mental illnesses and co-occurring substance use disorders. Psychiatric Rehabilitation Journal, 27, 360-74.
25. Edwards, J., Hinton, M., Elkins, K. & Athanasopoulos, O. (2003). Cannabis and first-episode psychosis: the CAP project. In H. L. Graham, A. Copello, M. J. Birchwood & K. T. Mueser (eds.), Substance Misuse in Psychosis: Approaches to Treatment and Service Delivery. Chichester, UK: John Wiley, pp. 283-304.
26. Edwards, J., Elkins, K., Hinton, M. et al. (2006). Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis. Acta Psychiatrica Scandinavica, 114, 109-17.
27. Evins, A. E., Mays, V. K., Rigotti, N. A. et al. (2001). A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia. Nicotine and Tobacco Research, 3, 397-403.
28. Fergusson, D. M., Horwood, L. J. & Swain-Campbell, N. R. (2003). Cannabis dependence and psychotic symptoms in young people. Psychological Medicine, 33, 15-21.
29. George, T. P., Ziedonis, D. M., Feingold, A. et al. (2000). Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. American Journal of Psychiatry, 157, 1835-42.
30. George, T. P., Vessicchio, J. C., Termine, A. et al. (2002). A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biological Psychiatry, 52, 53-61.
31. Gleeson, J, Jackson, H. J., Stavely, H. & Burnett, P. (1999). Family intervention in early psychosis. In P. D. McGorry & H. J. Jackson (eds.), The Recognition and Management of Early Psychosis. Cambridge, UK: Cambridge University Press, pp. 376-406.
32. Graham, H. L., Copello, A., Birchwood, M. J. et al. (2004). Cognitive-behavioural Integrated Treatment (C-BIT): A Treatment Manual for Substance Misuse in People with Severe Mental Health Problems. Chichester, UK: John Wiley.
33. Green, B., Kavanagh, D. & Young, R. M. (2004). Reasons for cannabis use in men with and without psychosis. Drug and Alcohol Review, 23, 445-53.
34. Gut-Fayand, A., Dervaux, A., Olie, J. et al. (2001). Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity. Psychiatry Research, 102, 65-72.
35. Haddock, G., Barrowclough, C., Tarrier, N. et al. (2003). Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18-month outcomes of a randomised controlled trial. British Journal of Psychiatry, 183, 418-26.
36. Hambrecht, M. & Häfner, H. (1996). Substance abuse and the onset of schizophrenia. Biological Psychiatry, 40, 1155-63.
37. Hambrecht, M. & Häfner, H. (1998). Are symptoms observed differently in male and female first-episode patients? Schizophrenia Research, 29, 186.
38. Hamera, E., Schneider, J. K. & Deviney, S. (1995). Alcohol, cannabis, nicotine, and caffeine use and symptom distress in schizophrenia. Journal of Nervous and Mental Disease, 183, 559-65.
39. Henquet, C., Murray, R., Linszen, D. & van Os, J. (2005). The environment and schizophrenia: the role of cannabis use. Schizophrenia Bulletin, 31, 608-12.
40. Hercus, M., Lubman, D.I. & Hellard, M. (2005). Blood borne viral and sexually transmissible infections among psychiatric populations: what are we doing about them? Australian and New Zealand Journal of Psychiatry, 39, 849-55.
41. Hides, L., Lubman, D. & Dawe, S. (2004). Models of co-occurring substance misuse and psychosis: are personality traits the missing link? Drug and Alcohol Review, 23, 425-32.
42. Hides, L., Dawe, S., Kavanagh, D. J. & Young, R. M. (2006). Psychotic symptom and cannabis relapse in recent-onset psychosis: a prospective study. British Journal of Psychiatry, 189, 137-43.
43. Hinton, M., Elkins, K., Edwards, J. & Donovan, K. (2002). Cannabis and Psychosis: An Early Psychosis Treatment Manual. Melbourne: Early Psychosis Prevention and Intervention Centre.
44. James, W., Preston, N. J., Koh, G. et al. (2004). A group intervention which assists patients with dual diagnosis reduce their drug use: a randomized controlled trial. Psychological Medicine, 34, 983-90.
45. Jeffery, D. P., Ley, A., McLaren, S. & Siegfried N. (2000). Psychosocial treatment programmes for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews, 2, CD001088. [DOI: 10.1002/14651858.CD001088].
46. Kavanagh, D. J., Mueser, K. T. & Baker, A. (2003a). Management of comorbidity. In M. Teesson & H. Proudfoot (eds.), Comorbid Mental Disorders and Substance Use Disorders: Epidemiology, Prevention and Treatment. Canberra: Commonwealth of Australia, pp. 78-120.
47. Kavanagh, D. J., Young, R., White, A. et al. (2003b). Start over and survive: a brief intervention for substance misuse in early psychosis. In H. L. Graham, A. Copello, M. J. Birchwood & K. T. Mueser (eds.), Substance Misuse in Psychosis: Approaches to Treatment and Service Delivery. Chichester, UK: John Wiley, pp. 244-58.
48. Kavanagh, D. J., Young, R., White, A. et al. (2004). A brief motivational intervention for substance misuse in recent- onset psychosis. Drug and Alcohol Review, 23, 151-5.
49. Kay-Lambkin, F.J., Baker, A.L. & Lewin, T.J. (2004). The ‘comorbidity roundabout’: a framework to guide assessment and intervention strategies and engineer change among people with comorbid problems. Drug and Alcohol Review, 23, 407-23.
50. Kemp, R., Kirov, G., Everitt, B., Hayward, P. & David, A. (1998). Randomised controlled trial of compliance therapy: 18-month follow-up. British Journal of Psychiatry, 172, 413-19.
51. Khantzian, E. (1985). The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. American Journal of Psychiatry, 142, 1259-64.
52. Lachman, H. M., Papolos, D. F., Saito, T. et al. (1996). Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics, 6, 243-50.
53. Lambert, M., Conus, P., Lubman, D. I. et al. (2005). The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis. Acta Psychiatrica Scandinavica, 112, 141-8.
54. Lewis, S. W., Tarrier, N. & Drake, R. J. (2005). Integrating non-drug treatments in early schizophrenia. British Journal of Psychiatry, 187, 65-71.
55. Linszen, D. H., Dingemans, P. M. & Lenior, M. E. (1994). Cannabis abuse and the course of recent-onset schizophrenic disorders. Archives of General Psychiatry, 51, 273-9.
56. Liraud, F. & Verdoux, H. (2000). Which temperamental characteristics are associated with substance use in subjects with psychotic and mood disorders? Psychiatry Research, 93, 63-72.
57. Martino, S., Carroll, K. M., O’Malley, S. S. & Rounsaville, B. J. (2000). Motivational interviewing with psychiatrically ill substance abusing patients. American Journal on Addictions, 9, 88-91.
58. McGorry, P. D. (1995). Psychoeducation in first-episode psychosis: a therapeutic process. Psychiatry, 58, 313-28.
59. McGorry, P., Killackey, E., Elkins, K., Lambert, M. & Lambert, T. (2003). Summary: Australian and New Zealand clinical practice guideline for the treatment of schizophrenia. Australasian Psychiatry, 11, 136-47.
60. McHugo, G. J., Drake, R. E., Burton, H. L. & Ackerson, T. H. (1995). A scale for assessing the stage of substance abuse treatment in persons with severe mental illness. Journal of Nervous and Mental Disease, 182, 164-7.
61. Miller, W. & Rollnick, S. (2002). Motivational Interviewing: Preparing People for Change. New York: Guilford Press.
62. Mueser, K. T. & Drake, R. E. (2003). Integrated dual disorder treatment in New Hampshire (USA). In H. L. Graham, A. Copello, M. J. Birchwood & K. T. Mueser (eds.), Substance Misuse in Psychosis: Approaches to Treatment and Service Delivery. Chichester, UK: John Wiley, pp. 93-105.
63. Mueser, K. T., Drake, R. E. & Wallach, M. A. (1998). Dual diagnosis: a review of aetiological theories. Addictive Behaviours, 23, 717-34.
64. Mueser, K.T., Rosenberg, S.D., Drake, R.E. et al. (1999). Conduct disorder, antisocial personality disorder and substance use disorders in schizophrenia and major affective disorders. Journal of Studies on Alcohol, 60, 278-84.
65. Nordentoft, M., Jeppesen, P., Abel, M. et al. (2002). OPUS study: suicidal behaviour, suicidal ideation and hopelessness among patients with first-episode psychosis - one-year follow-up of a randomised controlled trial. British Journal of Psychiatry, 181, 98-106.
66. Norman, R. M. G. & Malla, A. K. (2002). Examining adherence to medication and substance use as possible confounds of duration of untreated psychosis. Journal of Nervous and Mental Disease, 190, 331-4.
67. Osher, F. C. & Kofoed, L. L. (1989). Treatment of patients with psychiatric and psychoactive substance use disorders. Hospital and Community Psychiatry, 40, 1025-30.
68. Rabinowitz, J., Bromet, E. J., Carlson, L. G., Kovasznay, B. & Schwartz, J. E. (1998). Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients. Psychological Medicine, 28, 1411-19.
69. Regier, D. A., Farmer, M. E., Rae, D. S. et al. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) study. Journal of the American Medical Association, 264, 2511-18.
70. Robinson, D., Woerner, M. G., Alvir, J. M. J. et al. (1999). Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Archives of General Psychiatry, 56, 241-7.
71. Rollnick, S., Heather, N., Gold, R. & Hall, W. (1992). Development of a short ‘readiness to change’ questionnaire for use in brief, opportunistic interventions among excessive drinkers. British Journal of Addiction, 87, 743-54.
72. Rosenberg, S. D., Drake, R., Wolford, G. L. et al. (1998). Dartmouth Assessment of Lifestyle Instrument (DALI): a substance use disorder screen for people with severe mental illness. American Journal of Psychiatry, 155, 232-8.
73. Saunders, J. B., Aasland, O. G., Babor, T. F., de le Fuente, J. R. & Grant, M. (1993). Development of the alcohol use disorders identification test (AUDIT). WHO collaborative project on early detection of persons with harmful alcohol consumption. Addiction, 88, 791-804.
74. Semple, D. M., McIntosh, A. M. & Lawrie, S. M. (2005). Cannabis as a risk factor for psychosis: systematic review. Journal of Psychopharmacology, 19, 187-94.
75. Sevy, S., Robinson, D. G., Holloway, S. et al. (2001). Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder. Acta Psychiatrica Scandinavica, 104, 367-74.
76. Sorbara, F., Liraud, F., Assens, F., Abalan, F. & Verdoux, H. (2003). Substance use and the course of early psychosis: a 2-year follow-up of first-admitted subjects. European Psychiatry, 18, 133-6.
77. Spencer, C., Castle, D. & Michie, P. T. (2002). Motivations that maintain substance use among individuals with psychotic disorders. Schizophrenia Bulletin, 28, 233-47.
78. Strakowski, S. M., Keck, P. E., McElroy, S. L. et al. (1998). Twelve-month outcome after a first hospitalization for affective psychosis. Archives of General Psychiatry, 55, 49-55.
79. Swanson, A. J., Pantalon, M. V. & Cohen, K. R. (1999). Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients. Journal of Nervous and Mental Disease, 187, 630-5.
80. Van Mastrigt, S., Addington, J. & Addington, D. (2004). Substance misuse at presentation to an early psychosis program. Social Psychiatry and Psychiatric Epidemiology, 39, 69-72.
81. Verdoux, H., Liraud, F., Gonzales, B. et al. (2001). Predictors and outcome characteristics associated with suicidal behaviour in early psychosis: a two-year follow-up of first- admitted subjects. Acta Psychiatrica Scandinavica, 103, 347-54.
82. Verma, S. K., Subramaniam, M., Chong, S. A. & Kua, E. H. (2002). Substance abuse in schizophrenia: a Singapore perspective. Social Psychiatry and Psychiatric Epidemiology, 37, 326-8.
83. Voruganti, L. N. P., Slomka, P., Zabel, P., Mattar, A. & Awad, A. G. (2001). Cannabis induced dopamine release: an in-vivo SPECT study. Psychiatry Research Neuroimaging, 107, 173-7.
84. Wade, D., Harrigan, S., Edwards, J. et al. (2005). Patterns and predictors of substance use disorders and daily tobacco use in first-episode psychosis. Australian and New Zealand Journal of Psychiatry, 39, 892-8.
85. Wade, D., Harrigan, S., Edwards, J. et al. (2006a). Course of substance misuse and daily tobacco use in first-episode psychosis. Schizophrenia Research, 81, 145-50.
86. Wade, D., Harrigan, S., Edwards, J. et al. (2006b). Substance misuse in first-episode psychosis: 15-month prospective follow-up study. British Journal of Psychiatry, 189, 229-34.
87. WHO ASSIST Working Group (2002). The alcohol, smoking, and substance involvement screening test (ASSIST): development, reliability and feasibility. Addiction, 97, 1183-94.
88. Zammit, S., Allebeck, P., Andreasson, S., Lundberg, I. & Lewis, G. (2002). Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. British Medical Journal, 325, 1199-204.